You must be logged in to view this content
This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.
Many studies have shown that cataract surgery in ARMD patients may be performed safely and has the potential to improve visual acuity without driving progression to exudative AMD. Data are now emerging on a new class of ‘extended macular vision’ IOL designed to optimize the image supplied to all areas of the macula and not just the foveal centre.
We report a case of an 83-year old Caucasian female presenting with poor contrast sensitivity and color perception with increasing glare in the preceding year. Progressed cortical cataract and stable dry ARMD in the left eye and wet ARMD in the right eye were noted. Phacoemulsification was performed with small incision, capsular bag implantation of a new extended macular vision, single piece, soft acrylic IOL (eyemax mono IOL; LEH Pharma, London UK).
Visual acuity progressively improved after IOL implantation and was stable after 3 months, consistent with a neuro-adaptive component that may occur with this IOL design. No vision rehabilitation training was required. BCDVA improved from 0,05 to 0,5 and BCNVA from 0,05 to 0,2. During the entire observation period (1y) no symptoms of halos or glare were reported, no PCO was detected.
In this first case, cataract extraction and implantation of the eyemax mono was performed safely with pleasant outcome measures in line with the effects of image optimization across the macula. It constitutes a new class of monofocal IOL, designed specifically for patients with centre-involving macular disorders such as ARMD.